The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa.
暂无分享,去创建一个
A G Renwick | D G Waller | N. Wood | A. Renwick | C. George | A. Renwick | C F George | D. Waller | D R Robertson | N D Wood | H Everest | K Monks | D. Robertson | K. Monks | H. Everest | C. George | DG Waller | ND Wood
[1] Grant R. Wilkinson,et al. A physiological approach to hepatic drug clearance , 1975 .
[2] F. Caird,et al. LEVODOPA FOR PARKINSONISM IN ELDERLY AND DEMENTED PATIENTS , 1973, The Medical journal of Australia.
[3] J. Awapara,et al. Fluctuations in DOPA decarboxylase activity with age 1 , 1975, Journal of neurochemistry.
[4] D J Birkett,et al. Variability of L-dopa absorption in man. , 1974, Australian and New Zealand journal of medicine.
[5] S. Kaakkola,et al. The effect of an increased ratio of carbidopa to levodopa on the pharmacokinetics of levodopa , 1985, Acta neurologica Scandinavica.
[6] J. Nutt,et al. Pharmacokinetics of levodopa. , 1984, Clinical neuropharmacology.
[7] R. G. Mcallister. Age-related changes in drug handling in man. , 1986, The American journal of cardiology.
[8] L. Lasagna,et al. METABOLISM AND ABSORPTION OF l‐3,4 DIHYDROXYPHENYLALANINE IN PATIENTS WITH PARKINSON'S DISEASE , 1971, Annals of the New York Academy of Sciences.
[9] J. Durnin,et al. The assessment of the amount of fat in the human body from measurements of skinfold thickness , 1967, British Journal of Nutrition.
[10] A. Leon,et al. Absorption and metabolism of levodopa. , 1971, JAMA.
[11] N. White,et al. SENILE PARKINSONISM, A SURVEY OF CURRENT TREATMENT , 1981 .
[12] J. Nutt,et al. The effect of carbidopa on the pharmacokinetics of intravenously administered levodopa: The mechanism of action in the treatment of parkinsonism , 1985, Annals of neurology.
[13] R. Wurtman,et al. Effects of L-dopa administration of the concentrations of dopa, dopamine and norepinephrine in various rat tissues. , 1973, The Journal of pharmacology and experimental therapeutics.
[14] G. Forbes,et al. Adult lean body mass declines with age: some longitudinal observations. , 1970, Metabolism: clinical and experimental.
[15] K. Sasahara,et al. Dosage form design for improvement of bioavailability of levodopa IV: Possible causes of low bioavailability of oral levodopa in dogs. , 1981, Journal of pharmaceutical sciences.
[16] H. Creasey,et al. Gastric emptying rate and the systemic availability of levodopa in the elderly parkinsonian patient , 1981, Neurology.
[17] J. Wener,et al. Effects of Levodopa Therapy in Patients with Parkinson's Disease: Statistical Evidence for Reduced Tolerance to Levodopa in the Elderly , 1974, Journal of the American Geriatrics Society.
[18] R. Godwin-Austen,et al. Incidence of Side Effects from Levodopa during the Introduction of Treatment , 1971, British medical journal.
[19] C. Andrews,et al. Catecholamine Metabolism During Oral Administration of Levodopa: Effects of the Medication in Parkinson's Disease , 1972 .
[20] A. Bender. THE EFFECT OF INCREASING AGE ON THE DISTRIBUTION OF PERIPHERAL BLOOD FLOW IN MAN , 1965 .
[21] C. Freed,et al. BRAIN TISSUE AND PLASMA ASSAY OF L‐DOPA AND α‐METHYLDOPA METABOLITES BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION , 1979, Journal of neurochemistry.
[22] C. George. Drug Kinetics and Hepatic Blood Flow , 1979, Clinical pharmacokinetics.
[23] M. P. Dixon,et al. Serum Protein Patterns in ‘Normal’ and Pathological Ageing , 1964 .
[24] A. Bender. EFFECT OF AGE ON INTESTINAL ABSORPTION: IMPLICATIONS FOR DRUG ABSORPTION IN THE ELDERLY , 1968, Journal of the American Geriatrics Society.